Merrimack Pharmaceuticals 10K Form

Buy

62

MACK
Merrimack Pharmaceuticals

Last Price:

15.03

Seasonality Move:

-16.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02	10Q	MACK/Merrimack Pharmaceuticals Quarterly
2023-08-03	10Q	MACK/Merrimack Pharmaceuticals Quarterly
2023-05-04	10Q	MACK/Merrimack Pharmaceuticals Quarterly
2022-11-03	10Q	MACK/Merrimack Pharmaceuticals Quarterly
2022-08-04	10Q	MACK/Merrimack Pharmaceuticals Quarterly
2022-05-05	10Q	MACK/Merrimack Pharmaceuticals Quarterly

Receive MACK News And Ratings

See the #1 stock for the next 7 days that we like better than MACK

MACK Financial Statistics

Sales & Book Value

Annual Sales:	$144.27M
Cash Flow:	$-295K
Price / Cash Flow:	0
Annual Sales:	$1.31
Price / Book:	11.61

Profitability

EPS (TTM):	-0.08000
Net Income (TTM):	$-1.18M
Gross Margin:	$137.36M
Return on Equity:	0%
Return on Assets:	0%

Merrimack Pharmaceuticals Earnings Forecast

Key Merrimack Pharmaceuticals Financial Ratios

The Gross Profit Margin over the past 8 years for MACK is 95.21%.
The Selling, General & Administrative Expenses for MACK have been equal to 22.22% of Gross Profit Margin.
The Interest Expense is 0.00% of Operating Income.
Per Share Earnings over the last 15 years have been positive in 9 years.

Merrimack Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	MACK
CUSIP:	590328
Website:	merrimack.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

MACK Technical Analysis vs Fundamental Analysis

Buy

62

Merrimack Pharmaceuticals (MACK) is a Buy

Is Merrimack Pharmaceuticals a Buy or a Sell?

Merrimack Pharmaceuticals stock is rated a Buy
The current Merrimack Pharmaceuticals [MACK] share price is $14.98. The Score for MACK is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.